{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:04:33Z","timestamp":1783987473464,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02423-y","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:05:21Z","timestamp":1779267921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapy-induced tumor regression heterogeneity for early prediction of response and prognosis in HER2-positive breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Zewen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingliang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2423_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/852748","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal N, Iqbal N. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol Biol Int. 2014;2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/852748.","journal-title":"Mol Biol Int"},{"issue":"12","key":"2423_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3390\/ijms17122095","volume":"17","author":"Q Lv","year":"2016","unstructured":"Lv Q, Meng Z, Yu Y, Jiang F, Guan D, Liang C, et al. Molecular mechanisms and translational therapies for human epidermal receptor 2 positive breast cancer. IJMS. 2016;17(12):2095. https:\/\/doi.org\/10.3390\/ijms17122095.","journal-title":"IJMS"},{"issue":"9","key":"2423_CR3","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","volume":"5","author":"Y-J Qi","year":"2024","unstructured":"Qi Y-J, Su G-H, You C, Zhang X, Xiao Y, Jiang Y-Z, et al. Radiomics in breast cancer: current advances and future directions. Cell Rep. Med. 2024;5(9):101719. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101719.","journal-title":"Cell Rep. Med"},{"issue":"11","key":"2423_CR4","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1158\/0008-5472.CAN-22-1183","volume":"82","author":"W Mu","year":"2022","unstructured":"Mu W, Schabath MB, Gillies RJ. Images are data: challenges and opportunities in the clinical translation of radiomics. Cancer Res. 2022;82(11):2066\u201368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1183.","journal-title":"Cancer Res"},{"key":"2423_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fonc.2019.00433","volume":"9","author":"WJ Cui","year":"2019","unstructured":"Cui WJ, Wang C, Jia L, Ren S, Duan SF, Cui C, et al. Differentiation between G1 and G2\/G3 phyllodes tumors of breast using mammography and mammographic texture analysis. Front Oncol. 2019;9:433. https:\/\/doi.org\/10.3389\/fonc.2019.00433.","journal-title":"Front Oncol"},{"issue":"3","key":"2423_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.diii.2022.10.008","volume":"104","author":"C Xue","year":"2023","unstructured":"Xue C, Zhou Q, Xi H, Zhou J. Radiomics: a review of current applications and possibilities in the assessment of tumor microenvironment. Diagn Interv Imag. 2023;104(3):113\u201322. https:\/\/doi.org\/10.1016\/j.diii.2022.10.008.","journal-title":"Diagn Interv Imag"},{"key":"2423_CR7","doi-asserted-by":"publisher","unstructured":"Shi Z, Huang X, Cheng Z, Xu Z, Lin H, Liu C, et al. MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology. 2023;308(1):e222830. https:\/\/doi.org\/10.1148\/radiol.222830.","DOI":"10.1148\/radiol.222830"},{"issue":"6","key":"2423_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jamcollsurg.2017.08.027","volume":"225","author":"JJ Weber","year":"2017","unstructured":"Weber JJ, Jochelson MS, Eaton A, Zabor EC, Barrio AV, Gemignani ML, et al. MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer. J Am Coll Surgeons. 2017;225(6):740\u201346. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.08.027.","journal-title":"J Am Coll Surgeons"},{"issue":"1","key":"2423_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40644-024-00758-9","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Dai Y, Chen J, Yan F, Yang Y. MRI-based habitat imaging in cancer treatment: current technology, applications, and challenges. Cancer Imag. 2024;24(1):107. https:\/\/doi.org\/10.1186\/s40644-024-00758-9.","journal-title":"Cancer Imag"},{"issue":"1","key":"2423_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13058-024-01921-7","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen H, Liu Y, Zhao J, Jia X, Chai F, Peng Y, et al. Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: a multicenter study. Breast Cancer Res BCR. 2024;26(1):160. https:\/\/doi.org\/10.1186\/s13058-024-01921-7.","journal-title":"Breast Cancer Res BCR"},{"key":"2423_CR11","doi-asserted-by":"publisher","first-page":"103042","DOI":"10.1016\/j.ebiom.2020.103042","volume":"61","author":"AGV Bitencourt","year":"2020","unstructured":"Bitencourt AGV, Gibbs P, Rossi Saccarelli C, Daimiel I, Lo Gullo R, Fox MJ, et al. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer. Ebiomedicine. 2020;61:103042. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103042.","journal-title":"Ebiomedicine"},{"key":"2423_CR12","doi-asserted-by":"publisher","first-page":"103786","DOI":"10.1016\/j.breast.2024.103786","volume":"77","author":"Y Yu","year":"2024","unstructured":"Yu Y, Chen R, Yi J, Huang K, Yu X, Zhang J, et al. Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: a radiomics and deep learning analysis on longitudinal DCE-MRI data. Breast. 2024;77:103786. https:\/\/doi.org\/10.1016\/j.breast.2024.103786.","journal-title":"The Breast"},{"issue":"8","key":"2423_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","volume":"129","author":"V Nardone","year":"2024","unstructured":"Nardone V, Reginelli A, Rubini D, Gagliardi F, Del Tufo S, Belfiore MP, et al. Delta radiomics: an updated systematic review. Radiol Med (Torino). 2024;129(8):1197\u2013214. https:\/\/doi.org\/10.1007\/s11547-024-01853-4.","journal-title":"Radiol Med (Torino)"},{"issue":"12","key":"2423_CR14","doi-asserted-by":"publisher","first-page":"2413702","DOI":"10.1002\/advs.202413702","volume":"12","author":"Y Huang","year":"2025","unstructured":"Huang Y, Shi Z, Zhu T, Zhou T, Li Y, Li W, et al. Longitudinal MRI-driven multi-modality approach for predicting pathological complete response and B cell infiltration in breast cancer. Adv Sci. 2025;12(12):2413702. https:\/\/doi.org\/10.1002\/advs.202413702.","journal-title":"Adv Sci"},{"key":"2423_CR15","doi-asserted-by":"publisher","unstructured":"Rajesh A, Gurusamy DS, Manikkam R. Evaluating the tumor burden, histological changes, and immune landscape of breast cancer post-neoadjuvant chemotherapy: insights from 50 cases. Cureus. 2025;17:e80258. https:\/\/doi.org\/10.7759\/cureus.80258.","DOI":"10.7759\/cureus.80258"},{"issue":"2","key":"2423_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.62347\/GTIX2261","volume":"17","author":"L Xu","year":"2025","unstructured":"Xu L. Quantitative dynamic contrast-enhanced MRI parameters effectively predict treatment efficacy of neoadjuvant chemotherapy in breast cancer. Am J Transl Res. 2025;17(2):1039\u201348. https:\/\/doi.org\/10.62347\/GTIX2261.","journal-title":"Am J Transl Res"},{"issue":"2","key":"2423_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Criminol Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Criminol Cancer"},{"issue":"1","key":"2423_CR18","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJWL Aerts","year":"2014","unstructured":"Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5(1):4006. https:\/\/doi.org\/10.1038\/ncomms5006.","journal-title":"Nat Commun"},{"issue":"12","key":"2423_CR19","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1109\/TPAMI.2024.3435571","volume":"46","author":"R Azad","year":"2024","unstructured":"Azad R, Aghdam EK, Rauland A, Jia Y, Avval AH, Bozorgpour A, et al. Medical image segmentation review: the success of U-net. IEEE Trans Pattern Anal Mach Intell. 2024;46(12):10076\u201395. https:\/\/doi.org\/10.1109\/TPAMI.2024.3435571.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"2423_CR20","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.media.2020.101934","volume":"68","author":"K Chaitanya","year":"2021","unstructured":"Chaitanya K, Karani N, Baumgartner CF, Erdil E, Becker A, Donati O, et al. Semi-supervised task-driven data augmentation for medical image segmentation. Med Image Anal. 2021;68:101934. https:\/\/doi.org\/10.1016\/j.media.2020.101934.","journal-title":"Med Image Anal"},{"issue":"4","key":"2423_CR21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/jmri.29188","volume":"60","author":"Y Huang","year":"2024","unstructured":"Huang Y, Cao Y, Hu X, Lan X, Chen H, Tang S, et al. Early identification of pathologic complete response to neoadjuvant chemotherapy using multiphase DCE-MRI by siamese network in breast cancer: a longitudinal multicenter study. Magn Reson Imag. 2024;60(4):1325\u201337. https:\/\/doi.org\/10.1002\/jmri.29188.","journal-title":"Magn Reson Imag"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02423-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:07:34Z","timestamp":1783984054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02423-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2423"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02423-y","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Weifang Hospital of Traditional Chinese Medicine (approval number: No. 2025Y\u00d7378; approved on 26 March 2025). The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}